Foundayo, Lilly’s new oral GLP-1 pill for weight loss, now available in US
Eli Lilly and Company announced that Foundayo (orforglipron) is now available to adults with obesity or overweight with…
Author
OPPI collaborates with NIPER Rae Bareli to advance research excellence
The Organisation of Pharmaceutical Producers of India (OPPI) has announced a strategic collaboration with the National Institute…
Merck expands Bengaluru facility to boost global supply of filtration devices
Merck, a leading science and technology company, announced the expansion of its manufacturing facility in Peenya, Bengaluru. The…
Lupin receives ANDA approval for Dapagliflozin, Metformin Hydrochloride extended-release tablets in…
Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug…
Glenmark receives US FDA approval for Progesterone Vaginal Inserts, 100 mg
Glenmark Pharmaceuticals has received final approval from the United States Food & Drug Administration (US FDA) for…
Lupin receives US FDA approval for Dapagliflozin tablets
Approval confirms bioequivalence to Farxiga for approved indications
Inventia enters the U.S. market with FDA approved Dapagliflozin tablets
Approval grants eligibility for 180-day shared generic drug exclusivity
Biocon launches Bosaya and Aukelso in the United States
Denosumab biosimilars made available through specialty pharmacies and healthcare providers
Alembic Pharmaceuticals secures USFDA approval for Dapagliflozin Tablets ANDA
Approval grants eligibility for 180-day shared generic drug exclusivity
Lupin receives Great Place To Work certification across global operations
Recognition based on study covering subsidiaries and employee participation